Rhythm Pharmaceuticals director Christophe Jean reports sale of $1.1 million in common shares
RYTM•Director Christophe Jean sold 10,000 Rhythm Pharmaceuticals common shares on November 17, 2026, for about $1.1 million. He exercised options for 10,000 shares at $34.89 each and held 11,712 shares directly after the transactions.




